Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation. Issue 11 (2nd November 2018)

Record Type:: Journal Article
Title:: Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation. Issue 11 (2nd November 2018)
Main Title:: Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation
Authors:: Takei, Tomomi
Yokoyama, Kazuaki
Shimizu, Eigo
Konuma, Takaaki
Takahashi, Satoshi
Yamaguchi, Rui
Imoto, Seiya
Miyano, Satoru
Tojo, Arinobu
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 59:Issue 11(2018)
Journal:: Leukemia & lymphoma
Issue:: Volume 59:Issue 11(2018)
Issue Display:: Volume 59, Issue 11 (2018)
Year:: 2018
Volume:: 59
Issue:: 11
Issue Sort Value:: 2018-0059-0011-0000
Page Start:: 2755
Page End:: 2756
Publication Date:: 2018-11-02
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2018.1443335 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 9136.xml